What is the ticker symbol for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals trades under the ticker TARS on NASDAQ.

What sector does Tarsus Pharmaceuticals operate in?

Tarsus Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TARS in a portfolio?

PortView shows TARS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Tarsus Pharmaceuticals (TARS) Stock Analysis

NASDAQHealthcareBiotechnology

$78.88+6.52%

1-year price historyRange $49.36 – $82.51

52-week range$78.88

$48.20$85.25

What Tarsus Pharmaceuticals does

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.

Key metrics

Market cap

$3.39B

P/E (TTM)

-72.36

EPS (TTM)

$-1.09

Beta

0.51

Dividend yield

0.00%

Revenue / share

$13.97

50-day avg

$64.78

200-day avg

$68.55

52-week high

$85.25

52-week low

$48.20

CEO

Bobak R. Azamian

ETFs linked to TARS

Broad-market and Healthcare sector ETFs an investor holding Tarsus Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TARS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TARS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Tarsus Pharmaceuticals?: Tarsus Pharmaceuticals trades under the ticker TARS on NASDAQ.
Which exchange is TARS listed on?: TARS is listed on NASDAQ.
What sector does Tarsus Pharmaceuticals operate in?: Tarsus Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TARS in a portfolio?: PortView shows TARS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.